Stallion India FY26 PAT Rises 35.61% to ₹4,384 Lakhs
Stallion India Fluorochemicals Limited reported its audited financial results for the year ended March 31, 2026, showcasing a 35.61% rise in net profit to ₹4,384.11 lakhs. Total revenue increased by 14.40% to ₹43,412.30 lakhs, and EBITDA grew by 23.34% to ₹6,134.74 lakhs. The company successfully met its revenue target of approximately ₹430 crores despite global market volatility. Looking ahead, management projects a revenue CAGR of 30–35% over the next three years and targets a PAT of ₹100 crores for FY27, supported by the upcoming R-32 manufacturing facility in Bhilwara.
*this image is generated using AI for illustrative purposes only.
Stallion India Fluorochemicals Limited's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026. The company, a leading forward-integrated player in refrigeration and industrial gas, operates as a critical link in the industrial gas supply chain, focusing on processing, blending, and distributing specialised gases across multiple sectors. Following the results announcement, the company has made available the audio recording of the earnings conference call held on May 18, 2026.
Q4 FY26 Financial Performance
For the quarter ended March 31, 2026, the company reported a decline in revenue and net profit on a year-on-year basis. Revenue from operations stood at ₹10,999.43 lakhs, compared to ₹15,156.79 lakhs in Q4 FY25. Net profit for the quarter came in at ₹1,093.42 lakhs, down from ₹1,327.15 lakhs in the corresponding period of the previous year. EBITDA for Q4 FY26 stood at ₹1,764.83 lakhs, compared to ₹2,031.26 lakhs in Q4 FY25. The following table presents the key quarterly financial metrics:
| Metric: | Q4 FY26 | Q4 FY25 |
|---|---|---|
| Total Income: | ₹11,129.52 lakhs | ₹15,316.21 lakhs |
| EBITDA: | ₹1,764.83 lakhs | ₹2,031.26 lakhs |
| Net Profit (PAT): | ₹1,093.42 lakhs | ₹1,327.15 lakhs |
FY26 Annual Financial Performance
On a full-year basis, Stallion India Fluorochemicals delivered a strong performance, with total revenue growing 14.40% year-on-year to ₹43,412.30 lakhs in FY26 from ₹37,947.40 lakhs in FY25. EBITDA rose 23.34% to ₹6,134.74 lakhs from ₹4,973.99 lakhs, while net profit (PAT) increased 35.61% to ₹4,384.11 lakhs from ₹3,232.86 lakhs. EPS grew 21.92% to ₹5.34 from ₹4.38. The key annual financial metrics are presented below:
| Metric: | FY26 | FY25 | YoY Change |
|---|---|---|---|
| Total Revenue: | ₹43,412.30 lakhs | ₹37,947.40 lakhs | ↑ 14.40% |
| EBITDA: | ₹6,134.74 lakhs | ₹4,973.99 lakhs | ↑ 23.34% |
| Net Profit (PAT): | ₹4,384.11 lakhs | ₹3,232.86 lakhs | ↑ 35.61% |
| EPS (₹): | 5.34 | 4.38 | ↑ 21.92% |
Management Commentary
Mr. Shazad Rustomji, Managing Director & CEO of Stallion India Fluorochemicals Limited, commented on the company's performance: "We are pleased to report a resilient operational and financial performance for FY26 despite increasing volatility across global energy and supply-chain markets. During FY26, the Company reported Total Revenue of ₹434.12 crores, reflecting a YoY growth of 14.40%, while EBITDA increased by 23.34% to ₹61.35 crores and PAT increased by 35.61% to ₹43.84 crores, demonstrating the strength of our operating model and execution capabilities."
Mr. Rustomji noted that recent geopolitical developments have created supply-side pressures, but the company proactively strengthened its sourcing network and inventory planning. The company successfully achieved its targeted topline growth projection of approximately ₹430 crores. A key long-term growth driver is the proposed 10,000 MT R-32 manufacturing facility at Bhilwara, Rajasthan, for which Environmental Clearance has been received. The project is on track for commencement by October 2026.
Growth Outlook
Management anticipates a revenue CAGR of 30–35% over the next 3 years, along with a margin improvement of 3–4%. This guidance reflects confidence in operational capabilities, ongoing capacity expansion, and structural growth opportunities in the refrigerants and industrial gases sector. For FY27, the company targets a PAT of approximately ₹100 crores, driven by the commencement of the Bhilwara facility. The company has also outlined a long-term vision to achieve ₹3,000 crore revenue and ₹500 crore PAT by 2030.
Historical Stock Returns for Stallion India Fluorochemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.15% | +1.63% | +31.03% | -15.32% | +143.07% | +53.17% |
How will the commissioning of the Bhilwara R-32 manufacturing facility in October 2026 impact Stallion India's competitive positioning against established fluorochemical manufacturers in India?
Given the significant gap between Q4 FY26 revenue decline and the strong full-year growth, what seasonal or structural factors could influence quarterly performance consistency in FY27?
With management targeting a PAT jump from ₹43.84 crores in FY26 to approximately ₹100 crores in FY27, what execution risks could challenge this aggressive 128% profit growth target?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
